Group 3A: Metastatic Breast Cancer; Immune Microenvironment

Poster #PO1-13-04: Distinct immune signatures discriminate between patients defined as exceptional survivors of metastatic breast cancer compared to those with rapidly progressing treatment resistant breast cancers.

Poster #PO1-20-12: CD8+ tumor infiltrating lymphocytes turn a cold tumor hot in metastatic breast cancer.